The development history of ELISA technology is a story of scientific progress filled with innovation and breakthroughs. From its initial theoretical concept to its widespread application today, it has gradually matured through continuous exploration and improvement, bringing revolutionary changes to biomedical research and clinical diagnosis.

In Enzyme-Linked Immunosorbent Assay (ELISA), the standard curve is the core foundation for quantitative analysis of analytes, and its quality directly determines the reliability, accuracy, and reproducibility of experimental results. An ideal standard curve not only requires a good linear relationship but also needs to cover a dynamic detection range suitable for experimental needs to accurately reflect the true concentration of analytes in samples, providing strong support for scientific data interpretation and clinical detection judgments. The precise preparation of the standard curve relies first on the standardized handling of standards— reconstitution and gradient dilution. The operational standardization of these two links directly affects the accuracy of standard concentrations, thereby determining the quality of the entire standard curve, which is a key prerequisite for the success of ELISA experiments.

The success of ELISA experiments not only relies on high-quality kits and standardized operations but also离不开 scientific and reasonable experimental design — from mastering the principles of coating and blocking to planning microplate well positions, precise preparation of reagents, and standardizing details of the entire process operation. Each link directly affects the accuracy, repeatability, and reliability of experimental results.

This authoritative review article was published in Nature Reviews Drug Discovery in 2026, entitled Autophagy modulation in cancer. It was written by Emma Guilbaud, Kevin M. Ryan, Douglas R. Green and Lorenzo Galluzzi. The central premise of this article is that autophagy exerts diametrically opposite effects at distinct stages of cancer development and progression.

Enzyme-Linked Immunosorbent Assay (ELISA), as a widely used immunoquantitative technique in scientific research and clinical testing, relies on its high specificity and sensitivity to become the core method for antigen/antibody detection. However, the core of ELISA experiments lies in the assembly process of large immune complexes, which involves the synergistic interaction of multiple components such as antigens, antibodies, enzyme conjugates, and solid carriers. Any deviation in any component or operational step may lead to signal capture failure, affecting the accuracy and reliability of experimental results.

In ELISA experiments, the coefficient of determination (R²) of the standard curve is a core indicator for measuring the reliability of detection results and the stability of linear relationships, directly affecting the accuracy of target quantification— the closer R² is to 1, the better the linear correlation between standard concentration and detection signal, the higher the credibility of experimental data, and the easier it is to pass strict requirements such as paper review and clinical validation.

In Enzyme-Linked Immunosorbent Assay (ELISA), plate washing is a core critical step throughout the experiment. Its operational standardization directly affects the sensitivity, specificity, and accuracy of detection results, and is also an important link to avoid experimental errors and reduce false positive/negative results. Manual plate washing has become a widely used plate washing method in scientific research and clinical detection due to its flexible operation and adaptation to various laboratory scenarios. However, in actual operation, laboratory personnel often encounter problems such as high background, cross-contamination between wells, and abnormal color development due to improper control of operational details.

In Enzyme-Linked Immunosorbent Assay (ELISA), the standard curve is the core foundation for quantitative analysis of analytes. Its quality directly determines the reliability, accuracy, and reproducibility of experimental data, and is a key prerequisite for the success of ELISA experiments. The preparation of standard curves involves multiple steps such as standard processing, operational specifications, and experimental environment control. During actual operations, experimental personnel often face various questions regarding standard storage, dilution, curve fitting, etc.

In the fields of life sciences research, clinical testing, and drug development, antibodies are indispensable core tools. They possess an extraordinary ability to precisely recognize and specifically bind to antigens, serving as 'precision probes' for researchers to track biomolecules, detect pathological cells, and screen targeted drugs. However, natural antibodies themselves lack luminescence, color development, or signal characteristics, making it impossible to directly capture their binding trajectories or detect binding results with the naked eye or conventional instruments. To make the antibody's workflow 'visible and quantifiable,' it is necessary to use antibody labeling kits to achieve signal modification and functional enhancement of the antibody.

The research focuses on the anti-inflammatory mechanisms of propionic acid and butyric acid, exploring their core molecular targets and signaling axes for targeted regulation of intestinal immune inflammation. At the same time, by integrating clinical samples and small-scale clinical trials, it aims to validate the clinical application potential of SCFAs intervention in ulcerative colitis, providing new theoretical support for dietary intervention and precision therapy in intestinal inflammation.